Bone marrow‐restricted aberrant myeloperoxidase expression in B‐acute lymphoblastic leukemia: A diagnostic dilemma and mimicry of mixed phenotype acute leukemia
Wei J. Wang,
Brandon T. Gehris,
Daniel Rivera,
Sibel Ak,
David Feng,
Wei Wang,
Zhihong Hu
Affiliations
Wei J. Wang
Department of Pathology and Laboratory Medicine The University of Texas Health Science Center at Houston Houston Texas USA
Brandon T. Gehris
Department of Pathology and Laboratory Medicine The University of Texas Health Science Center at Houston Houston Texas USA
Daniel Rivera
Department of Pathology and Laboratory Medicine The University of Texas Health Science Center at Houston Houston Texas USA
Sibel Ak
Department of Pathology and Laboratory Medicine The University of Texas Health Science Center at Houston Houston Texas USA
David Feng
Foster High School Richmond Texas USA
Wei Wang
Department of Hematopathology The University of Texas MD Anderson Cancer Center Houston Texas USA
Zhihong Hu
Department of Laboratory Medicine The University of Texas MD Anderson Cancer Center Houston Texas USA
Abstract Myeloperoxidase (MPO) is the most specific marker of the myeloid lineage, essential for diagnosing acute myeloid leukemia and mixed phenotype acute leukemia with myeloid components. In this regard, we present a unique case of B‐acute lymphoblastic leukemia (B‐ALL) with isolated MPO expression in bone marrow blasts detected by flow cytometry and immunohistochemistry, while peripheral blood blasts were negative for MPO expression. In this report, our discussion encompasses diagnostic pitfalls from a laboratory testing perspective in similar cases and includes a literature review. Furthermore, we emphasize the necessity of conducting a comprehensive analysis for the accurate diagnosis of MPO‐positive B‐ALL cases.